Waters presents a new video on its UPLC Systems, Mass Spectrometers and SDMS software solutions

NewsGuard 100/100 Score

Waters Corporation (NYSE: WAT) has posted a new version of its online video showcase featuring compelling interviews with more than 50 scientists, development partners, and product experts in the fields of pharmaceutical discovery and development, food safety, environmental analysis, sports medicine, disease research and clinical toxicology and clinical research. The showcase features interviews with scientists speaking about their research and business imperatives, their partnership with Waters, and the impact of Waters® ACQUITY® UltraPerformance LC® (UPLC®) Systems, Xevo(TM) and SYNAPT(TM) Mass Spectrometers, and Empower(TM) and NuGenesis(TM) SDMS software and Informatics solutions on helping achieve scientific and business success. Waters Video Showcase is accessible at www.waters.com/customers and is the largest such collection of expert testimonials in the industry.

Giving visionaries, leading scientists and experts a unique platform for communicating their passion for science and the role of instrumentation and software in helping them achieve their vision, Waters Video Showcase has opened a window onto the men and women playing an important role in understanding the biology of disease, discovering new drug compounds, keeping food safe to eat and water safe to drink, diagnosing treatable metabolic disorders, and giving hope to those managing chronic diseases. The ever-expanding video showcase features interviews with scientists at the following leading academic institutions, independent laboratories, and manufacturers including AIT Laboratories, Inc., Alexza Pharmaceuticals, Apotex, Inc., Beijing Institute of Radiation Medicine, Certified Laboratories, Dominion Diagnostics, Duke University, ICON Development Solutions, Imperial College London, Kings College London, Lundebeck USA, Northeastern University, Pharmaron (Beijing), PharmaVite, Quotient Bioresearch, University of Amsterdam, University of Castelleon (Spain), University of California Davis, University of Cambridge (London), University of Leeds, University of Warwick, Van Andel Research Institute, and Xenotech LLC.

SOURCE Waters Corporation


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
When mass spectrometry redefines the pharma industry